HIV 暴露后预防引起的两系血细胞减少症：一例报告。
HIV post exposure prophylaxis induced bicytopenia: a case report.
机构信息
Center for Infectious Diseases and Infection Control, Jena University Hospital, Erlanger Allee 101, Jena, Thuringia 07740, Germany.
出版信息
AIDS Res Ther. 2014 Feb 7;11(1):11. doi: 10.1186/1742-6405-11-11.
Abstract
Long and short term side effects of antiretroviral drugs are not fully understood yet. Here a case of reversible blood count changes following post exposure prophylaxis with tenofovir/emtricitabin and lopinavir/ritonavir is reported. We propose that antiretroviral drugs used in post exposure prophylaxis may have a significant impact on hematopoiesis.
摘要
抗逆转录病毒药物的长期和短期副作用尚未完全了解。在此报告了一例在接触后预防中使用替诺福韦/恩曲他滨和洛匹那韦/利托那韦后出现可逆的血细胞计数变化的病例。我们提出，接触后预防中使用的抗逆转录病毒药物可能对造血有重大影响。
相似文献
1
HIV post exposure prophylaxis induced bicytopenia: a case report.HIV 暴露后预防引起的两系血细胞减少症：一例报告。
AIDS Res Ther. 2014 Feb 7;11(1):11. doi: 10.1186/1742-6405-11-11.
2
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis.富马酸替诺福韦二吡呋酯/恩曲他滨联合利托那韦增效洛匹那韦或考比司他增效艾维雷韦用于 HIV 暴露后预防的单一片剂方案。
J Antimicrob Chemother. 2017 Oct 1;72(10):2857-2861. doi: 10.1093/jac/dkx246.
3
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.一项随机临床试验，比较利托那韦增强型洛匹那韦与马拉维若分别联合替诺福韦加恩曲他滨用于HIV感染暴露后预防的效果。
J Antimicrob Chemother. 2016 Jul;71(7):1982-6. doi: 10.1093/jac/dkw048. Epub 2016 Mar 18.
4
HIV exposure through contact with body fluids.通过接触体液感染艾滋病毒。
Prescrire Int. 2012 Apr;21(126):100-1, 103-5.
5
Antiretroviral therapies in women after single-dose nevirapine exposure.女性单次奈韦拉平暴露后的抗逆转录病毒治疗。
N Engl J Med. 2010 Oct 14;363(16):1499-509. doi: 10.1056/NEJMoa0906626.
6
7
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.延长洛匹那韦-利托那韦与拉米夫定预暴露预防方案以减少非洲通过母乳喂养传播 HIV-1 至婴儿 50 周：一项随机对照试验。（ANRS 12174）
Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19.
8
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.一项随机临床试验，比较利托那韦增强型洛匹那韦与拉替拉韦，二者均联合替诺福韦加恩曲他滨用于HIV感染暴露后预防。
J Antimicrob Chemother. 2016 Jul;71(7):1987-93. doi: 10.1093/jac/dkw049. Epub 2016 Mar 18.
9
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.女性生殖道中的抗逆转录病毒药物暴露：对口服暴露前和暴露后预防的影响。
AIDS. 2007 Sep 12;21(14):1899-907. doi: 10.1097/QAD.0b013e328270385a.
10
Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.在乌干达和马拉维，与未感染 HIV 的未暴露儿童相比，产前和产后抗逆转录病毒暴露对 HIV 暴露和未感染儿童的神经发育影响：一项前瞻性队列研究。
Lancet HIV. 2019 Aug;6(8):e518-e530. doi: 10.1016/S2352-3018(19)30083-9. Epub 2019 May 20.
引用本文的文献
1
Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara Regional Referral Hospital, southwestern Uganda.乌干达西南部姆巴拉拉地区转诊医院免疫抑制综合征诊所中未接受过抗逆转录病毒治疗的艾滋病毒感染者的血液学异常情况。
J Blood Med. 2018 Jun 27;9:105-110. doi: 10.2147/JBM.S157148. eCollection 2018.
2
Suspected unexpected and other adverse reactions to antiretroviral drugs used as post-exposure prophylaxis of HIV infection - five-year experience from clinical practice.用于HIV感染暴露后预防的抗逆转录病毒药物的疑似意外及其他不良反应——临床实践五年经验
Arch Med Sci. 2018 Apr;14(3):547-553. doi: 10.5114/aoms.2016.59701. Epub 2016 May 5.
本文引用的文献
1
Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.人类免疫缺陷病毒感染的血液学表现及高效抗逆转录病毒疗法对血细胞减少的影响。
Korean J Hematol. 2011 Dec;46(4):253-7. doi: 10.5045/kjh.2011.46.4.253. Epub 2011 Dec 27.
2
3
[Post-exposure prophylaxis of HIV infection. German-Austrian recommendations, update September 2007].[HIV感染的暴露后预防。德国-奥地利建议，2007年9月更新]
Dtsch Med Wochenschr. 2009 Jan;134 Suppl 1:S16-33. doi: 10.1055/s-0028-1123966. Epub 2009 Jan 26.
4
Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.洛匹那韦/利托那韦和茚地那韦引起的一名HIV感染患者血小板减少症
Int J Infect Dis. 2004 Sep;8(5):315-6. doi: 10.1016/j.ijid.2004.05.001.
5
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.强效抗逆转录病毒治疗相关不良事件的患病率：瑞士HIV队列研究
Lancet. 2001 Oct 20;358(9290):1322-7. doi: 10.1016/s0140-6736(01)06413-3.
Zotero 插件